Caesarean Scar Revision With the UltraPulse

Scar Revision Clinical Trial

Official title: Caesarean Scar Revision With the UltraPulse

Status Completed

Clinical Trial Summary

Ten (10) adult female subjects that had a caesarean surgery performed.Study will be conducted in 1 site.

Each subject will receive three treatments on one area that was randomly chosen. The other area will be left untreated and will serve as a control.

The objective is to Evaluate the clinical impact of UltraPulse fractional carbon dioxide laser treatment on the appearance of a Caesarean Scar (CS) as compared to a similar untreated scar side.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Scar Revision

• NCT number: NCT02050126
• Study type: Interventional
• Source: Lumenis Ltd.
• Status: Completed
• Phase: N/A
• Start date: April 2013
• Completion date: January 2016